FNIH, Geoffrey Beene Foundation Name Winner of Alzheimer’s Challenge

To advance the study of male/female differences in Alzheimer’s disease (AD), the organizers of a neurodiscovery challenge have announced the winner of the $50,000 grand prize. The organizers—the Foundation for the National Institutes of Health (FNIH) and the Geoffrey Beene Foundation—had narrowed the field of potential winners to just three. Ultimately, in a voting process that included public participation, the winner emerged: Enrico Glaab, Ph.D., a research associate at the Luxembourg Centre for Systems Biomedicine, University of Luxembourg.

Read the full article.

Loading

Winner of the Geoffrey Beene Global Neurodiscovery Challenge

Enrico Glaab, Ph.D., the winner of the Geoffrey Beene Global Neurodiscovery Challenge, will use his prize to continue his study of age-related gender differences in brain expression levels of a particular protein, tau-interacting ubiquitin-specific peptidase 9, and possible implications for Alzheimer’s disease.

Read the full article.

Loading

Thank You for Participating in the 2013 Geoffrey Beene Global NeuroDiscovery Challenge!

Congratulations to Luxembourg researcher Enrico Glaab, Ph.D., who yesterday won the $50,000 Geoffrey Beene Global NeuroDiscovery Challenge for research proposals on gender differences in Alzheimer’s disease. Glaab, of the Luxembourg Centre for Systems Biomedicine at the University of Luxembourg, will examine whether certain genes are expressed differently in men and women, and whether one gene (USP9Y) may be protective in men, explaining the increased risks for Alzheimer’s disease in women.

Read the full article.

Loading

Disrupting Alzheimer’s Disease Research

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that devastates the brain—affecting cognitive function, memory, visual spatial perception, abstract thinking, and eventually loss of bodily functions. Based on the latest Rand report on dementia and AD, the current costs in lives lost, families shattered, careers disrupted, and financial futures ruined is much too high. And with the projected increases in the number of individuals affected by AD and related dementias in coming years, the global costs become unendurable and insupportable.

Read the full article.

Loading

Global Forum

Meryl Comer speaks at the 2013 Global Forum: “Our mission is early AD diagnosis, which further defines our role as a catalyst funder for open source ‘Global NeuroDiscovery’ challenges that aim to advance innovation in self- administered mobile applications for brain health, Alzheimer’s clinical trial data mining for sex- based differences, and validation studies of mobile digital devices for assessing and tracking early cognitive decline.”

Read Meryl’s full remarks.

Loading

Geoffrey Beene Foundation Alzheimer’s Initiative Announces $100,000 Innovation Challenge

Washington, DC (April 30, 2013) — The Geoffrey Beene Foundation Alzheimer’s Initiative last night launched the 2013 Geoffrey Beene Global NeuroDiscovery Challenge at the April 29 Society for Women’s Health Research Gala at the Mandarin Hotel in Washington, DC. It is the Foundation’s second online innovation challenge, but the first to ask solvers to identify male/female differences in early cognitive decline, to promote earlier interventions for both women and men. Winning submissions will share $100,000 in prize awards.

2013-Geoffrey-Beene-Global-NeuroDiscovery-Challenge-Press-Release.

Loading